IRS1 regulation by wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype
(2009) Journal of Biological Chemistry — n° 3, p. 1928-1938 (2010)
Files
gb19843521.pdf
Restricted Access - Adobe PDF
- 2.62 MB
Details
- Authors
- Abstract
- Dysregulation of beta-catenin levels and localization and constitutive activation of beta-catenin/TCF (T cell factor)-regulated gene expression occurs in many cancers, including the majority of colorectal carcinomas (CRCs) and a subset of ovarian endometrioid adenocarcinomas (OEAs). Based on the results of microarray-based gene expression profiling we found the insulin receptor substrate 1 (IRS1) gene as one of the most highly upregulated genes upon ectopic expression of a mutant, constitutively active form of beta-catenin in the rat kidney epithelial cell line RK3E. We demonstrate that expression of IRS1 can be directly activated by beta-catenin, likely in part via beta-catenin/TCF binding to TCF consensus binding elements located in the first intron and downstream of the IRS1 transcriptional start site. Consistent with the proposal that beta-catenin is an important regulator of IRS1 expression in vivo, we observed that IRS1 is highly expressed in many cancers with constitutive stabilization of beta-catenin, such as CRCs and OEAs. Using an shRNA approach to abrogate IRS1 expression and function, we found IRS1 function is required for efficient de novo neoplastic transformation by beta-catenin in RK3E cells. Our findings add to the growing body of data implicating IRS1 as a critical signaling component in cancer development and progression.
- Affiliations
Citations
Bommer, G., Feng, Y., Iura, A., Giordano, T. J., Kuick, R., Kadikoy, H., Sikorski, D., Wu, R., Cho, K. R., & Fearon, E. R. (2009). IRS1 regulation by wnt/beta-catenin signaling and varied contribution of IRS1 to the neoplastic phenotype. Journal of Biological Chemistry, 3, 1928-1938. https://hdl.handle.net/2078.5/134167 (Original work published 2010)